In summary, BAP1 can exert its inhibitory effect on ccRCC by regulating multiple target genes and signaling pathways via interactions with the transcription factor YY1 and the histone-binding protein RBBP7. The gene discussed is RBBP7; the disease is nonpapillary renal cell carcinoma.